Activity of the fourth generation cephalosporin FK-037 against methicillin-resistantStaphylococcus aureus under conditions maximizing PBP2′ production
- 1 December 1994
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 13 (12) , 1053-1055
- https://doi.org/10.1007/bf02111826
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Activity of β-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1993
- Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroximeAntimicrobial Agents and Chemotherapy, 1993
- Antibiogram typing of methicillin-resistant staphylococcus aureus: A comparison with phage typing, biotyping and API StaphZentralblatt für Bakteriologie, 1993
- Effects of culture media on detection of methicillin resistance in Staphylococcus aureus and coagulase negative staphylococci by disc diffusion methods.Journal of Clinical Pathology, 1993
- In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporinAntimicrobial Agents and Chemotherapy, 1993
- Japan: Control of MRSA infectionThe Lancet, 1993
- In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporinAntimicrobial Agents and Chemotherapy, 1993
- Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.The Journal of Antibiotics, 1993
- In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporinAntimicrobial Agents and Chemotherapy, 1993
- Methicillin-Resistant Staphylococcus aureusNew England Journal of Medicine, 1989